Mosharov, E., Cranford, M
Studies comparing multiple surgeons evaluating the same patients show agreement rates as low as 60% for endometriosis identification
The 250mcg per dose format is the most commonly studied research administration volume
The analysis found that patients taking tirzepatide were significantly more likely to achieve weight loss: Those taking tirzepatide were 1.8 times more likely than those taking semaglutide to achieve 5% weight loss, 2.6 times more likely than those taking semaglutide to achieve 10% weight loss, And three times more likely than those taking semaglutide to achieve 15% weight loss
*We reserve the right to refuse treatment to those who are inappropriate for treatment
Include Targeted Supplements and Therapies Functional medicine providers can recommend IV therapy, bioidentical hormones, or acupuncture to further support your weight loss journey